APONTIS PHARMA AG

Highlights Apontis Pharma AG

Equities

APPH

DE000A3CMGM5

Market Closed - Xetra Other stock markets 09:06:06 28/06/2024 pm IST			5-day change	1st Jan Change
8.6 ^EUR	0.00%		-0.69%	+81.05%

05/04	Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	MT
28/03	Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	05/04	MT
Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Apontis Pharma Provides Earnings Guidance for the Full Year 2023	09/11	CI
Apontis Pharma AG Reports Earnings Results for the Half Year Ended June 30, 2023	11/23/11	CI
AstraZeneca Cancels Lung Disease Drug Co-promotion Deal With Apontis Pharma	01/23/01	MT
Aontis Pharma AG Launches Single Pill Finder and Distribution of Single Pill Rosazimib	29/23/29	CI
Apontis Pharma Ag Provides Revenue Guidance for the Year 2023	03/23/03	CI
Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Apontis Pharma In-Licenses Single Pill for Hypertension, Hyperlipidemia Treatment	31/23/31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer